Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer

M. E.J.M. Verhaegh; C. J.G. Sanders; J. W. Arends; H. A.M. Neumann

Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer

M. E.J.M. Verhaegh, C. J.G. Sanders, J. W. Arends, H. A.M. Neumann^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

68 Citations (Scopus)

Abstract

Basal cell carcinoma (BCC) is typically a slow-growing malignant tumour, composed of cells similar to those in the basal area of the epidermis. We investigated the expression of bcl-2 (B-cell leukaemia/lymphoma-2) in BCC, and also in squamous cell carcinoma (SCC) of the skin. The proto-oncogene bcl-2 encodes a protein which inhibits programmed cell death (apoptosis). The protein is expressed in basal cells in normal human epithelium, but not in the suprabasal cell layers. Immunohistochemical localization using a monoclonal anti-Bcl-2 antibody revealed bcl-2 expression in all the BCCs (15 patients). SCCs did not express bcl-2 (five patients). The positive Bcl-2 staining of BCC tumour cells supports the hypothesis that BCCs originate from the basal layer of the epidermis. The bcl-2 expression of BCC tumour cells also suggests a neoplastic transformation caused by extended cell survival rather than increased cell proliferation. This type of neoplastic growth is possibly associated with less aggressive tumour behaviour.

Original language	English
Pages (from-to)	740-744
Number of pages	5
Journal	British Journal of Dermatology
Volume	132
Issue number	5
Publication status	Published - 1 Jan 1995

Cite this

@article{82c724723cb24bb0a2ffa2e0e232c14f,

title = "Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer",

abstract = "Basal cell carcinoma (BCC) is typically a slow-growing malignant tumour, composed of cells similar to those in the basal area of the epidermis. We investigated the expression of bcl-2 (B-cell leukaemia/lymphoma-2) in BCC, and also in squamous cell carcinoma (SCC) of the skin. The proto-oncogene bcl-2 encodes a protein which inhibits programmed cell death (apoptosis). The protein is expressed in basal cells in normal human epithelium, but not in the suprabasal cell layers. Immunohistochemical localization using a monoclonal anti-Bcl-2 antibody revealed bcl-2 expression in all the BCCs (15 patients). SCCs did not express bcl-2 (five patients). The positive Bcl-2 staining of BCC tumour cells supports the hypothesis that BCCs originate from the basal layer of the epidermis. The bcl-2 expression of BCC tumour cells also suggests a neoplastic transformation caused by extended cell survival rather than increased cell proliferation. This type of neoplastic growth is possibly associated with less aggressive tumour behaviour.",

author = "Verhaegh, {M. E.J.M.} and Sanders, {C. J.G.} and Arends, {J. W.} and Neumann, {H. A.M.}",

year = "1995",

month = jan,

day = "1",

language = "English",

volume = "132",

pages = "740--744",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer

AU - Verhaegh, M. E.J.M.

AU - Sanders, C. J.G.

AU - Arends, J. W.

AU - Neumann, H. A.M.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Basal cell carcinoma (BCC) is typically a slow-growing malignant tumour, composed of cells similar to those in the basal area of the epidermis. We investigated the expression of bcl-2 (B-cell leukaemia/lymphoma-2) in BCC, and also in squamous cell carcinoma (SCC) of the skin. The proto-oncogene bcl-2 encodes a protein which inhibits programmed cell death (apoptosis). The protein is expressed in basal cells in normal human epithelium, but not in the suprabasal cell layers. Immunohistochemical localization using a monoclonal anti-Bcl-2 antibody revealed bcl-2 expression in all the BCCs (15 patients). SCCs did not express bcl-2 (five patients). The positive Bcl-2 staining of BCC tumour cells supports the hypothesis that BCCs originate from the basal layer of the epidermis. The bcl-2 expression of BCC tumour cells also suggests a neoplastic transformation caused by extended cell survival rather than increased cell proliferation. This type of neoplastic growth is possibly associated with less aggressive tumour behaviour.

AB - Basal cell carcinoma (BCC) is typically a slow-growing malignant tumour, composed of cells similar to those in the basal area of the epidermis. We investigated the expression of bcl-2 (B-cell leukaemia/lymphoma-2) in BCC, and also in squamous cell carcinoma (SCC) of the skin. The proto-oncogene bcl-2 encodes a protein which inhibits programmed cell death (apoptosis). The protein is expressed in basal cells in normal human epithelium, but not in the suprabasal cell layers. Immunohistochemical localization using a monoclonal anti-Bcl-2 antibody revealed bcl-2 expression in all the BCCs (15 patients). SCCs did not express bcl-2 (five patients). The positive Bcl-2 staining of BCC tumour cells supports the hypothesis that BCCs originate from the basal layer of the epidermis. The bcl-2 expression of BCC tumour cells also suggests a neoplastic transformation caused by extended cell survival rather than increased cell proliferation. This type of neoplastic growth is possibly associated with less aggressive tumour behaviour.

UR - http://www.scopus.com/inward/record.url?scp=0029031985&partnerID=8YFLogxK

M3 - Article

C2 - 7772478

AN - SCOPUS:0029031985

SN - 0007-0963

VL - 132

SP - 740

EP - 744

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 5

ER -

Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer

Abstract

Other files and links

Fingerprint

Cite this